We’re experiencing issues for some mobile devices with our ARTG dataset filter function. We apologise for any inconvenience while we work to fix this.
MAR-MIDODRINE (midodrine hydrochloride) 2.5mg tablets (Marcan Pharmaceuticals, Canada)
Section 19A approved medicine
MAR-MIDODRINE (midodrine hydrochloride) 2.5mg tablets (Marcan Pharmaceuticals, Canada)
Section 19A approval holder
Southern XP IP Pty Ltd ABN 55 639 505 570
Phone
03 7067 8510
Approved until
Status
Current
Medicines in short supply/unavailable
VASODRINE midodrine hydrochloride 2.5 mg immediate release tablet blister pack - ARTG 309183
Indication(s)
Indicated in adults for the treatment of severe symptomatic orthostatic hypotension due to autonomic dysfunction when exacerbating factors have been addressed and other forms of treatment remain inadequate.
Additional information
Canadian medication labels use specific two‑letter month abbreviations in the expiry date to accommodate bilingual (English/French) labelling. Further infromation can be found here: https://www.ismp-canada.org/download/AcceptableAbbreviations-ISMPCanada…
Images
